Michelleanne Bradley

Michelleanne Bradley is a seasoned professional in Drug Safety, Pharmacovigilance, Compliance, and Quality Assurance Services, currently serving as President at Metis Consulting Services since October 2016. With a robust background that includes roles such as Director of Drug Safety and Pharmacovigilance at Immune Design and Galena Biopharma, and a Drug Safety Manager at Onyx Pharmaceuticals, Michelleanne has extensive experience in audit readiness, gap analysis, and the development of scalable systems. Prior positions include consulting for Edge Alliance, operations management at Amgen, and various roles in safety and regulatory affairs. Michelleanne holds a BA in Spanish, Women's Studies, and Latin American Studies from The University of Georgia.